Kristen Ambrose Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Feb 06, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Kristen Ambrose

CAO

TXN 2025-02-04 · FILED 2025-02-06

Equity Position 11.9K sh 7,500 → 11,920

Equity Change +58.9% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Vertex Pharmaceuticals Inc MA

VRTX CIK 0000875320

Reporting Owner

Name	Relationship
Kristen Ambrose CIK 0001856587	CAO

Kristen Ambrose at Vertex Pharmaceuticals Inc MA Full insider history

Bought (12 mo) —

Sold (12 mo) $1,978,865

More from this insider at Vertex Pharmaceuticals Inc MA

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-02-04	A - Award/Grant	2,566 A	$0.00	—	10,066	Direct
Common StockF2	2025-02-04	A - Award/Grant	1,854 A	$0.00	—	11,920	Direct

Footnotes (2)

F1: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Show more
F2: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Vertex Pharmaceuticals Inc MA

GET /v1/forms/4/0000875320-25-000007 API docs